Alan Kohler has interview Richard Jagger, CEO of BGT. Very much a 'beginner's guide' to BGT for the layman, with a few touches of humour, and a perfect introduction or revision for some as well.
Can you tell us in words of one syllable how your molecules kill the pests versus how other ones do and what does it do, strangle them versus shooting them, or what?
It interacts with the nervous system of the insects. The exact details I can’t share with you at the moment because that’s subject to some IP that at this stage we want to keep to ourselves but it works on a particular channel within the nervous system that is very different to what other insecticides interact with within those nerve cells if that makes sense. Tell us about your patents, how far have you got along that journey?
Sure, so our patent that we have at the moment is very generalised, it’s about using beta triketones as insecticides, so a very general patent. The issue with it is that it was applied for many years ago so it actually has five years left on that life and as you can appreciate from a commercial aspect with the work we still need to do before registration that doesn’t leave a lot of time. What we have done in the middle of last year we applied for some additional patents and we’re creating some specific data around that at the moment to support those patent applications. That’s enabling us to get really more specific about how the technology is used and how the technology interacts with insects to control them and, if you like, it gives us a better and stronger net around our patent position. In addition to that we’ve also been able to accumulate some additional IP that probably won’t use this patent, will keep it as inside information and a lot of that might relate to how we manufacture the synthetic molecule and even how we harvest the natural product out of the trees and create those products ready for application use.
BGT Price at posting:
17.5¢ Sentiment: None Disclosure: Not Held
